Nimotuzumab with Induction Chemotherapy and Chemo-Radiation in Patients with Advanced Head and Neck Cancer

Journal of Cancer Therapy

ISSN Print: 2151-1934
ISSN Online: 2151-1942
www.scirp.org/journal/jct
E-mail: jct@scirp.org

Citations h5-index & Ranking

Journals Menu

"Nimotuzumab with Induction Chemotherapy and Chemo-Radiation in Patients with Advanced Head and Neck Cancer"
written by Sundaram Subramanium, Venkatanarayan Balasundaram, Sridharan Nithya, Poojar Kiran,
published by Journal of Cancer Therapy, Vol.6 No.2, 2015

has been cited by the following article(s):

Google Scholar
CrossRef

[1]	Therapeutic approaches for the treatment of head and neck squamous cell carcinoma–An update on clinical trials
	Translational …, 2022

[2]	TÁC DỤNG GÂY HOẠI TỬ TẾ BÀO UNG THƯ CỦA VIRUS VACCIN SỞI VÀ NIMOTUZUMAB
	Tạp chí Y học Việt Nam, 2021

[3]	Intravoxel Incoherent Motion Magnetic Resonance Imaging for Prediction of Induction Chemotherapy Response in Locally Advanced Hypopharyngeal Carcinoma …
	2021

[4]	Nimotuzumab Combined with Induction Chemotherapy and Concurrent Chemoradiotherapy in Unresectable Locally Advanced Hypopharyngeal Carcinoma …
	2020

[5]	Therapeutic applications of herbal/synthetic/bio-drug in oral cancer: An update
	2020

[6]	Efficacy and safety of concurrent chemoradiotherapy with or without Nimotuzumab in unresectable locally advanced squamous cell carcinoma of head and …
	2019

[7]	Joint Editors: Dr. Kumar Prabhash
	2019

[8]	Efficacy and safety of concurrent chemoradiotherapy with or without Nimotuzumab in unresectable locally advanced squamous cell carcinoma of head and neck …
	2019

[9]	Efficacy and safety of nimotuzumab in unresectable, recurrent, and/or metastatic squamous cell carcinoma of the head and neck: A hospital-based …
	2018

[10]	Application of molecular targeted therapies in the treatment of head and neck squamous cell carcinoma
	2018

[11]	Efficacy and safety of nimotuzumab in unresectable, recurrent, and/or metastatic squamous cell carcinoma of the head and neck: a hospital-based retrospective …
	2018

[12]	Retrospective analysis to assess the feasibility of escalated dose of nimotuzumab in patients with locally advanced head and neck cancer
	2017

[1]	Therapeutic approaches for the treatment of head and neck squamous cell carcinoma–An update on clinical trials Translational Oncology, 2022 DOI:10.1016/j.tranon.2022.101426

[2]	Nimotuzumab Combined with Neoadjuvant or Induction Chemotherapy for Head and Neck Squamous Cell Carcinoma: A Retrospective Study Oncologie, 2022 DOI:10.32604/oncologie.2022.027023

[3]	Intravoxel Incoherent Motion Magnetic Resonance Imaging for Prediction of Induction Chemotherapy Response in Locally Advanced Hypopharyngeal Carcinoma: Comparison With Model‐Free Dynamic Contrast‐Enhanced Magnetic Resonance Imaging Journal of Magnetic Resonance Imaging, 2021 DOI:10.1002/jmri.27537

[4]	Therapeutic applications of herbal/synthetic/bio-drug in oral cancer: An update European Journal of Pharmacology, 2021 DOI:10.1016/j.ejphar.2020.173657

[5]	Nimotuzumab Combined with Induction Chemotherapy and Concurrent Chemoradiotherapy in Unresectable Locally Advanced Hypopharyngeal Carcinoma: A Single Institution Experience in China Cancer Management and Research, 2020 DOI:10.2147/CMAR.S248392

[6]	Retracted : Nimotuzuma restrains proliferation and induces apoptosis in human osteosarcoma cells by regulation of EGFR/PI3K/AKT signal pathway Journal of Cellular Physiology, 2019 DOI:10.1002/jcp.28693

[7]	Retracted : Nimotuzuma restrains proliferation and induces apoptosis in human osteosarcoma cells by regulation of EGFR/PI3K/AKT signal pathway Journal of Cellular Physiology, 2019 DOI:10.1002/jcp.28693

	+1 323-425-8868
	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

	+1 323-425-8868
	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Journal of Cancer Therapy

Journal of Cancer Therapy

Journals Menu

Home

About SCIRP

Service

Policies